AP
Highly rated in
65
conditions

Dr. Amy S. Paller

Outpatient Center In Northbrook
Northbrook, IL
Highly rated in
65
conditions
Specialties:Pediatrics | Dermatology
Experience:45 Years
Clinical Trials:Currently Recruiting for 9 Trials
Accepts:New Patients
Highly rated in
65
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

    View 77 More Conditions +
    Check Dr. Amy S. Paller's experience treating your condition:
    About Dr. Amy S. Paller

    Amy Paller is a Pediatrics specialist and a Dermatologist in Northbrook, Illinois. Paller has been practicing medicine for over 45 years and is highly rated in 65 conditions, according to our data. Her top areas of expertise are Atopic Dermatitis, Nonbullous Congenital Ichthyosiform Erythroderma, Lamellar Ichthyosis, and Netherton Syndrome. She is licensed to treat patients in Illinois. Paller is currently accepting new patients.

    Her clinical research consists of co-authoring 346 peer reviewed articles and participating in 42 clinical trials in the past 15 years.

    Insurance

    MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Amy S. Paller it is best to call her office and ask if your insurance is accepted.

    Dr. Amy S. Paller accepts the following insurance:

    •  Ambetter
    Call to see if your plan is accepted.
    Locations
    1131 Techny Rd, Northbrook, IL 60062
    Other Locations
    676 N St Clair St, Suite 1600, Chicago, IL 60611
    225 E Chicago Ave, Chicago, IL 60611
    Background & Education
    Graduate Institution
    Stanford University School Of Medicine, 1978
    Specialties
    Pediatrics
    Dermatology
    Licenses
    Pediatrics in IL
    Hospital Affiliations
    Northwestern Memorial Hospital
    Ann & Robert H Lurie Childrens Hospital Of Chicago
    Languages Spoken
    English
    Gender
    Female
    Clinical Research

    Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

    42 Clinical Trials
    A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Lebrikizumab Compared to Placebo in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
    Enrollment Status: Recruiting
    Publish Date: December 09, 2022
    Intervention Type: Drug
    Study Phase: Phase 3
    A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
    Enrollment Status: Recruiting
    Publish Date: December 05, 2022
    Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
    Enrollment Status: Recruiting
    Publish Date: November 29, 2022
    Systems Biology of Early Atopy
    Enrollment Status: Recruiting
    Publish Date: August 08, 2022
    An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses.
    Enrollment Status: Recruiting
    Publish Date: April 20, 2022
    Intervention Type: Drug
    Study Drug: Ustekinumab
    Study Phase: Early Phase 1
    Defining the Skin and Blood Biomarkers of Ichthyosis
    Enrollment Status: Recruiting
    Publish Date: April 06, 2022
    Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis SUB-STUDY: Defining the Predictive Non-Invasive Biomarkers for Pediatric Atopic Dermatitis (Funded by Regeneron Pharmaceuticals, Inc.)
    Enrollment Status: Recruiting
    Publish Date: April 06, 2022
    Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment
    Enrollment Status: Recruiting
    Publish Date: April 06, 2022
    Intervention Type: Other
    Open Label Treatment of Beremagene Geperpavec (B-VEC)
    Enrollment Status: Recruiting
    Publish Date: June 09, 2021
    Intervention Type: Biological
    Study Drug: Open Label Topical Beremagene Geperpavec (B-VEC)
    Study Phase: Phase 3
    Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders: a Single-Site Pilot Study
    Enrollment Status: Not yet recruiting
    Publish Date: December 13, 2022
    Intervention Type: Drug
    Study Phase: Early Phase 1
    Characterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray Solution
    Enrollment Status: Not yet recruiting
    Publish Date: December 09, 2022
    Intervention Type: Combination Product
    Study Phase: Early Phase 1
    A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
    Enrollment Status: Active, not recruiting
    Publish Date: December 08, 2022
    Intervention Type: Biological
    Study Drug: Lebrikizumab
    Study Phase: Phase 3
    A Randomized,Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of RGN-137 Topical Gel in Subjects With Junctional and Dystrophic Epidermolysis Bullosa (CELEB)
    Enrollment Status: Terminated
    Publish Date: August 22, 2022
    Intervention Type: Drug
    Study Drug: RGN-137
    Study Phase: Phase 2
    Pilot Study of Utilizing Topical Sodium Hypochlorite to Ameliorate or Reduce Radiation Dermatitis
    Enrollment Status: Terminated
    Publish Date: August 17, 2022
    Intervention Type: Other
    Study Phase: Not Applicable
    Brief Cognitive Behavioral Therapy to Treat Itch Rumination Itch CBT in Eczema
    Enrollment Status: Active, not recruiting
    Publish Date: August 16, 2022
    Intervention Type: Behavioral
    Study Phase: Not Applicable
    A Phase III Double Blinded, Placebo-Controlled, Efficacy and Safety Study of Beremagene Geperpavec (B-VEC, Previously KB103) for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)
    Enrollment Status: Completed
    Publish Date: August 03, 2022
    Intervention Type: Biological, Other
    Study Drug: Topical Beremagene Geperpavec
    Study Phase: Phase 3
    An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
    Enrollment Status: Completed
    Publish Date: July 25, 2022
    Intervention Type: Biological
    Study Drug: Lebrikizumab
    Study Phase: Phase 3
    A Smart, Always -On Health Monitoring System, Sub-Study: No Strings Attached: Wireless Sensor Technology in the Prentice NICU
    Enrollment Status: Completed
    Publish Date: June 14, 2022
    Intervention Type: Device
    Genetic Analysis of Pediatric Psoriasis
    Enrollment Status: Completed
    Publish Date: April 20, 2022
    Intervention Type: Other
    The Impact of Pediatric Skin Disorders: The Big Study
    Enrollment Status: Completed
    Publish Date: April 06, 2022
    A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of SB206 and Vehicle Gel Once Daily in the Treatment of Molluscum Contagiosum
    Enrollment Status: Completed
    Publish Date: April 01, 2022
    Intervention Type: Drug
    Study Phase: Phase 3
    A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
    Enrollment Status: Completed
    Publish Date: December 14, 2021
    Intervention Type: Combination Product
    Study Phase: Phase 3
    Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
    Enrollment Status: Completed
    Publish Date: September 27, 2021
    Intervention Type: Drug
    Study Phase: Phase 3
    A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses
    Enrollment Status: Completed
    Publish Date: August 25, 2021
    Intervention Type: Drug
    Study Phase: Phase 2
    An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
    Enrollment Status: Completed
    Publish Date: November 10, 2020
    Intervention Type: Drug
    Study Phase: Phase 1
    AAD-PEPR: Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments Sub-Study: Clinically Relevant Endpoints in Atopic Dermatitis in Children (CREAD-C)--Funded by Regeneron
    Enrollment Status: Completed
    Publish Date: October 09, 2020
    Intervention Type: Other
    Study Phase: Not Applicable
    Pre-SunBeam Pilot Study: Comparative Assessment of TEWL Measurements From AquaFlux vs. Handheld GPSkin Pro in Young Children With and Without AD
    Enrollment Status: Completed
    Publish Date: September 07, 2020
    Intervention Type: Device
    Study Phase: Not Applicable
    A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
    Enrollment Status: Completed
    Publish Date: April 09, 2020
    Intervention Type: Drug
    Study Phase: Phase 3
    An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
    Enrollment Status: Terminated
    Publish Date: November 05, 2019
    Intervention Type: Drug
    Study Phase: Phase 2
    Determining Effects of Superfine Sheep Wool in INfantile Eczema (DESSINE 2): a Multicentre Randomized Crossover Study
    Enrollment Status: Unknown status
    Publish Date: August 06, 2019
    Intervention Type: Other
    Study Phase: Not Applicable
    Randomized, Double-Blind, Parallel Group, Non-Inferiority Clinical Trial of CeraVe Baby Diaper Rash Cream Compared to Desitin Maximum Strength Original Paste for Management of Diaper Dermatitis in Infants
    Enrollment Status: Terminated
    Publish Date: March 13, 2018
    Intervention Type: Drug
    Study Phase: Not Applicable
    A Split-Face, Paired-Comparison, Pilot Study to Evaluate Safety and Efficacy of Two Topical Salicylic Acid 1.0% Creams for Mild to Moderate Acne Vulgaris
    Enrollment Status: Completed
    Publish Date: March 01, 2018
    Intervention Type: Drug
    Study Phase: Not Applicable
    Open-label, Pilot Study to Investigate the Safety and Tolerability of Alwextin 3.0% Cream in the Treatment of Epidermolysis Bullosa
    Enrollment Status: Completed
    Publish Date: February 28, 2018
    Intervention Type: Drug
    Study Phase: Phase 2
    A Split-face, Paired-comparison Pilot Study to Evaluate the Safety and Efficacy of Topical Benzoyl Peroxide 2.5% Cream Alone Versus Benzoyl Peroxide 2.5% Cream Plus Moisturizing Lotion for Mild to Moderate Acne Vulgaris
    Enrollment Status: Completed
    Publish Date: September 26, 2017
    Intervention Type: Drug
    Study Phase: Not Applicable
    Open-label, Pilot Study to Assess Cholesterol-Lovastatin Solution in the Treatment of Syndromic Ichthyoses
    Enrollment Status: Withdrawn
    Publish Date: May 19, 2015
    Intervention Type: Drug
    Study Phase: Phase 2
    Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population
    Enrollment Status: Completed
    Publish Date: May 01, 2015
    Intervention Type: Genetic
    Study Phase: Not Applicable
    A Split-face, Paired-comparison, Pilot Study to Evaluate Safety and Efficacy of Two Topical Benzoyl Peroxide 10.0% Creams for Mild to Moderate Acne Vulgaris
    Enrollment Status: Completed
    Publish Date: May 01, 2015
    Intervention Type: Drug
    Study Phase: Not Applicable
    Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris
    Enrollment Status: Completed
    Publish Date: April 14, 2015
    Intervention Type: Drug
    Study Phase: Phase 2
    Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
    Enrollment Status: Completed
    Publish Date: April 14, 2015
    Intervention Type: Other
    The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis
    Enrollment Status: Completed
    Publish Date: December 08, 2014
    Intervention Type: Drug
    Study Phase: Phase 4
    The Use of Text Messages to Improve Adherence to Health Maintenance Behaviors in Adolescents With Atopic Dermatitis
    Enrollment Status: Completed
    Publish Date: December 03, 2012
    Intervention Type: Procedure
    Study Phase: Not Applicable
    Systemic Therapies for Pediatric Atopic Dermatitis
    Enrollment Status: Unknown status
    Publish Date: November 04, 2012
    View 33 Less Clinical Trials -
    347 Total Publications
    Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis.
    Journal: Dermatology and therapy
    Published: July 14, 2022
    Save this doctor for later
    Sign Up
    Looking for the best doctor for you?
    Start Here
    Is this your doctor?
    Find a second opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn more
    Similar Doctors
    KA
    Dr. Kyle T. Amber
    Dermatology
    Highly rated in
    14
    conditions
    Dermatology

    Rush University System for Health

    Rush University Medical Center

    3249 S. Oak Park Avenue, 
    Berwyn, IL 
     19.6 mi

    Kyle Amber is a Dermatologist in Berwyn, Illinois. Amber has been practicing medicine for over 9 years and is highly rated in 14 conditions, according to our data. His top areas of expertise are Bullous Pemphigoid, Pemphigus, Pemphigus Vulgaris, and Pemphigus Foliaceus. He is licensed to treat patients in California and Illinois. Amber is currently accepting new patients.

    AM
    Dr. Anthony J. Mancini
    Pediatrics | Dermatology
    Highly rated in
    11
    conditions
    Pediatrics
    Dermatology

    Outpatient Center In Northbrook

    1131 Techny Rd, 
    Northbrook, IL 

    Anthony Mancini is a Pediatrics specialist and a Dermatologist in Northbrook, Illinois. Mancini is highly rated in 11 conditions, according to our data. His top areas of expertise are Hemangioma, Vascular Birthmark, PHACE Syndrome, and Aplasia Cutis Congenita. He is licensed to treat patients in Illinois. Mancini is currently accepting new patients.

    PG
    Pedram M. Gerami
    Dr. Pedram M. Gerami
    Dermatology
    Highly rated in
    18
    conditions
    Dermatology

    Northwestern Medicine

    Department Of Radiology

    676 N Saint Clair St, 
    Chicago, IL 
     18.0 mi

    Pedram Gerami is a Dermatologist in Chicago, Illinois. Gerami has been practicing medicine for over 22 years and is highly rated in 18 conditions, according to our data. His top areas of expertise are Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Tieche-Jadassohn Nevus, and Giant Congenital Melanocytic Nevus. He is licensed to treat patients in Illinois. Gerami is currently accepting new patients.